NASDAQ
ARYx Therapeutics, Inc. (ARYX) has a free cash flow growth of -15.33% as of Friday, May 29, 2026. This represents a 172.10% decrease compared to its 12-month average of 21.27%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.